Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

TRENDING TOPICS:

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Nov 19 2015

Full Issue

AMA Calls For Ban On Prescription Drug Advertising To Consumers

The doctors' group says the marketing could be driving up demand for expensive treatment that may be unnecessary.

The Chicago Tribune: AMA Doesn't Want You To See Those Cialis Ads

The American Medical Association on Tuesday called for a ban on consumer advertising for prescription drugs and medical devices, saying such marketing could be driving demand for unnecessary expensive treatments. The Chicago-based association said it adopted a policy supporting an advertising ban and called for greater transparency in prescription drug prices and costs. The policy was adopted by physicians at an AMA meeting in Atlanta. (Russell, 11/18)

The Washington Post: American Medical Association Urges Ban On TV Drug Ads

The resolution, approved by the AMA’s House of Delegates, has no immediate impact as only the Food and Drug Administration or Congress has the power to ban pharmaceutical advertising. ... According to the AMA, as more people seek drugs they may not need from doctors who may not be willing to prescribe them, drug prices and the money spent on selling them is on the rise. The group reported an 30 percent uptick in the money spent on DTC ads in the past two years, now a total of $4.5 billion. (Moyer, 11/19)

Marketplace: Doctors Vote To Stop Drug Ads To Consumers

Julie Donohue, an associate professor at the University of Pittsburgh’s Graduate School of Public Health, has studied direct-to-consumer drug advertising for 15 years. She said even if the federal government were to ban the ads, “it’s very unlikely the ban would stand up to a legal challenge, which would almost certainly be mounted by both the pharmaceutical industry and media.” (Scott, 11/18)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF